HIV coinfection with tuberculosis laboratory findings
|
HIV coinfection with tuberculosis Microchapters |
|
Differentiating HIV coinfection with tuberculosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV coinfection with tuberculosis laboratory findings On the Web |
|
American Roentgen Ray Society Images of HIV coinfection with tuberculosis laboratory findings |
|
FDA on HIV coinfection with tuberculosis laboratory findings |
|
CDC on HIV coinfection with tuberculosis laboratory findings |
|
HIV coinfection with tuberculosis laboratory findings in the news |
|
Blogs on HIV coinfection with tuberculosis laboratory findings |
|
Directions to Hospitals Treating HIV coinfection with tuberculosis |
|
Risk calculators and risk factors for HIV coinfection with tuberculosis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Laboratory Findings
A new rapid diagnostic test for TB disease, the Xpert MTB/RIF assay (which is not currently approved by the US Food and Drug Administration for use in the US), is expected to reduce patient and health service diagnostic delays, decentralize the diagnosis of MDR TB and HIV-associated TB, and accelerate patient access to appropriate care. Evidence suggests that use of the test might double the number of HIV-associated TB cases diagnosed in areas with high rates of TB and HIV.
Rapid HIV tests, using finger-prick or oral specimens, can also be used. Results are available in about 20 minutes. The rapid HIV test kits cost about $10. Although the rapid HIV test kits cost more than standard lab assays, they have been shown to be cost-effective. Also they increase patients’ acceptance to HIV testing. Another option is to collect oral swab specimens and use standard lab assays.
To read more about other lab test, click here.